Published in Med J Aust on November 01, 1975
Studies on the transfer of subviral infectivity from SV40-induced hamster tumor cells to indicator cells. Virology (1966) 4.16
Activation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus-free" human cells (complement-fixing antigen-immunofluorescence-leukocytes). Proc Natl Acad Sci U S A (1972) 3.89
To resuscitate or not, that is the question. Med J Aust (1989) 1.93
Induction of cellular DNA synthesis in human leukocytes by Epstein-Barr virus. Nature (1971) 1.91
Complement-fixing antibodies in sera of human and nonhuman primates to viral antigens derived from Burkitt's lymphoma cells. Proc Natl Acad Sci U S A (1967) 1.91
Selective transformation of B lymphocytes by E.B. virus. Lancet (1973) 1.84
A new tumour-derived transforming strain of Epstein-Barr virus. Nature (1978) 1.84
Studies on leukocytes growing in continuous culture derived from normal human donors. J Natl Cancer Inst (1968) 1.80
B-cell characteristics of human peripheral and cord blood lymphocytes transformed by Epstein-Barr virus. J Natl Cancer Inst (1974) 1.75
Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet (1972) 1.71
How far should we investigate and treat prostate cancer? A lawyer's perspective. Med J Aust (1994) 1.71
Herpesvirus papio DNA is similar in organization to Epstein-Barr virus DNA. J Virol (1981) 1.54
Confidentiality and the AMA's new code of ethics. Med J Aust (1997) 1.38
Epstein-Barr virus-induced viral and soluble complement-fixing antigens in Burkitt lymphoma cell cultures. Proc Soc Exp Biol Med (1970) 1.37
Antigens and DNA of a chimpanzee agent related to Epstein-Barr virus. J Virol (1976) 1.37
Infectious mononucleosis: complement-fixing antibodies to herpes-like virus associated with Burkitt lymphoma. Science (1968) 1.30
Biologic and antigenic characteristics of Epstein-Barr virus-related Herpesviruses of chimpanzees and baboons. Int J Cancer (1977) 1.29
In vitro stimulation of human lymphocytes by Epstein-Barr virus. Cell Immunol (1972) 1.26
Epstein-Barr virus-associated antigens activated in human cells by 5-bromodeoxyuridine. Proc Soc Exp Biol Med (1972) 1.26
DNA of herpesvirus pan, a third member of the Epstein-Barr virus-Herpesvirus papio group. J Virol (1982) 1.24
Immunoferritin and immunofluorescent studies with Epstein-Barr virus and herpes simplex virus by use of human sera and hyperimmune rabbit sera. J Natl Cancer Inst (1970) 1.19
Symptomatology of late-life minor depression among primary care patients. Psychosomatics (1990) 1.15
Comparative studies of Epstein-Barr virus strains from Ghana and the United States. Int J Cancer (1976) 1.07
Determination of the disulphide bonding pattern in proteins by local and global analysis of nuclear magnetic resonance data. Application to flavoridin. J Mol Biol (1993) 1.06
Association of EB-virus infection with the post-perfusion syndrome. Lancet (1969) 1.05
HL-A antigens of human lymphoid cells in long-term tissue culture. Transplantation (1969) 1.00
NIH clinical staff conference. Burkitt's tumor. Ann Intern Med (1969) 0.98
The incidence of complement-fixing antibodies to herpes simplex and herpes-like viruses in man and rhesus monkeys. Proc Soc Exp Biol Med (1968) 0.98
Leukocyte transforming agent (Epstein-Barr virus) in newborn infants and older individuals. J Pediatr (1976) 0.96
Attempts to transmit infectious mononucleosis to rhesus monkeys and marmosets and to isolate herpes-like virus. Proc Soc Exp Biol Med (1969) 0.95
Patterns of antibodies to SV40 in children following the last booster with inactivated poliomyelitis vaccines. Proc Soc Exp Biol Med (1967) 0.94
Murine leukemia viruses: rupture with ether and detergents to subviral constituents. Natl Cancer Inst Monogr (1966) 0.93
[Humidifier lung]. Schweiz Med Wochenschr (1981) 0.92
Relationship of Epstein-Barr virus-induced membrane antigens in lymphoid cells to viral envelope antigens. J Immunol (1970) 0.91
Comparison of the Raji cell line fluorescent antibody to membrane antigen test and the enzyme-linked immunosorbent assay for determination of immunity to varicella-zoster virus. J Clin Microbiol (1982) 0.90
Oncogenic herpesviruses of nonhuman primates. Comp Immunol Microbiol Infect Dis (1979) 0.89
Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics. J Natl Cancer Inst (1980) 0.87
Retention of Teflon particles in hamster lungs: a stereological study. J Aerosol Med (2000) 0.87
Functional hypoglycemia in early latent diabetes. Ann N Y Acad Sci (1968) 0.87
Prenatal cytogenetic diagnosis: some potential legal implications. Med J Aust (1985) 0.86
Epstein-Barr virus and human malignancy. Ann Intern Med (1977) 0.85
Oral excretion of E.B. virus. Lancet (1973) 0.85
Evidence for intravascular coagulation in systemic onset, but not polyarticular, juvenile rheumatoid arthritis. Arthritis Rheum (1985) 0.85
Lymphoproliferative disorders in an IL-7 transgenic mouse line. Leukemia (1993) 0.85
Productive Epstein-Barr viral infection of the human lymphoblastoid cell line 6410 with release of early antigen inducing and transforming virus. Int J Cancer (1977) 0.83
Combination of daptomycin plus ceftriaxone is more active than vancomycin plus ceftriaxone in experimental meningitis after addition of dexamethasone. Antimicrob Agents Chemother (2009) 0.82
Prevalence of depression and its correlates in a general medical practice. J Affect Disord (1987) 0.82
Isolation of plasma membrane antigens from Epstein-Barr virus-infected lymphoid cells. J Natl Cancer Inst (1973) 0.81
Who has the right to advise children on birth control? Med J Aust (1986) 0.81
Complement-fixing antibodies reactive with Epstein-Barr virus in sera of marmosets and prosimians. Proc Soc Exp Biol Med (1974) 0.80
Murine leukemia viruses: antigenic studies by quantitative complement fixation. Science (1966) 0.80
Infectious mononucleosis in acute leukemia with rising Epstein-Barr virus antibody titers. Ann Intern Med (1970) 0.79
Routine experimental system for defining conditions used in photodynamic therapy and fluorescence photodetection of (non-) neoplastic epithelia. J Biomed Opt (2001) 0.79
Heterotransplantation of two human lymphoid cell lines transformed in vitro by Epstein-Barr virus. J Natl Cancer Inst (1971) 0.79
Rational treatment of the obese diabetic. Postgrad Med (1968) 0.79
[Experimental studies of the significance and mechanism of desensitization to the gonadotropin-inhibiting effect of estrogen. 2. Detection and mechanisms of preovulatory desensitization in the ovarian cycle]. Zentralbl Gynakol (1986) 0.79
Persistence of transforming and nontransforming Epstein-Barr virus in high passages of P3HR-1 cell lines. J Natl Cancer Inst (1982) 0.78
[Hydroxylapatite-coated total prosthesis of the hip]. Helv Chir Acta (1990) 0.78
Evidence that inhibition of medial preoptic dopaminergic activity may be involved in the prepubertal desensitization to the negative oestrogen feedback in female rats. Exp Clin Endocrinol (1984) 0.76
Gender differences in a type 2 (non-insulin-dependent) diabetic population with respect to apolipoprotein E phenotype frequencies. Diabetologia (1993) 0.76
Psychiatric symptoms in the elderly in a primary care practice. Gen Hosp Psychiatry (1987) 0.76
The breast cancer screening controversy continues. Ann Intern Med (1993) 0.75
Urticaria due to blue dye in synthroid tablets. Thyroid (1994) 0.75
Functional hypoglycemia, the link between obesity and diabetes. Can Fam Physician (1968) 0.75
Infectious mononucleosis preceding acute myelomonocytic leukemia. Am J Med Sci (1975) 0.75
Gillett's case, the sequel. Intern Med J (2008) 0.75
"Donations" to in-vitro fertilization programmes. Med J Aust (1988) 0.75
Medical consultation--contract versus tort? Med J Aust (1985) 0.75
[Semiautomatic insulin injection equipment (pens)]. Schweiz Rundsch Med Prax (1990) 0.75
Informed consent--the last of Mrs Sidaway? Med J Aust (1985) 0.75
Compulsory admission of the mentally ill. Med J Aust (1986) 0.75
The seizure of medical records. Med J Aust (1985) 0.75
"To bury Caesar or to praise him?" The Savage affair as restoration drama. Med J Aust (1986) 0.75
Lymphoproliferative effect of Epstein-Barr virus on normal human lymphocytes in cultures. Bibl Haematol (1970) 0.75
Once a patient always a patient. Med J Aust (1991) 0.75
AIDS and the ethics of disclosure. Med J Aust (1987) 0.75
Vasectomies are legal--even in Queensland. Med J Aust (1987) 0.75
Medical tribunals--a lawyer's nightmare. Med J Aust (1969) 0.75
Evidence that desensitization to the negative estrogen feedback is a prepubertal and not a postpubertal event in female rats. Exp Clin Endocrinol (1984) 0.75
Tell it to the Marines. Med J Aust (1985) 0.75
[The cost of anesthesia]. Krankenpfl Soins Infirm (1991) 0.75
So-called C marker chromosome and Epstein-Barr virus. J Natl Cancer Inst (1970) 0.75
[Is pleurodesis for the treatment of spontaneous pneumothorax obsolete?]. Helv Chir Acta (1985) 0.75
The right to operate. Med J Aust (1990) 0.75
Ethics and drug trials. Med J Aust (1988) 0.75
The Health Insurance Act and the privilege against self-incrimination. Med J Aust (1985) 0.75
Legal liability of public hospitals. Med J Aust (1986) 0.75
Parents' opinions in 1956 and in 1979 about the etiology of cerebral palsy. Dev Med Child Neurol (1984) 0.75
No hawkers, canvassers or solicitors! Med J Aust (1990) 0.75
Medial preoptic area, estrogen, and the peripubertal desensitization to the negative estrogen feedback in female rats. Neuroendocrinology (1984) 0.75
Varying sensitivity to the negative oestrogen feedback during the ovarian cycle of female rats: evidence for the involvement of oestrogen and the medial preoptic area. J Endocrinol (1984) 0.75
New regulations on sterilization. Med J Aust (1990) 0.75
The looming storm. Med J Aust (1987) 0.75
Medical negligence and legal causation--where the twain do not meet. Med J Aust (1986) 0.75
[Significance and mechanism of desensitization to the gonadotropin-inhibiting effect of estrogen. 1. Studies on prepubertal desensitization]. Zentralbl Gynakol (1984) 0.75
Oestrogen-induced desensitization to the negative oestrogen feedback. A mechanism involved in the sex-specific control of gonadotrophin secretion during sexual maturation and in adulthood. Monogr Neural Sci (1986) 0.75
Viral etiology of the postperfusion syndrome. Am Heart J (1970) 0.75
Children and birth control. Med J Aust (1986) 0.75
Some aspects of the appeals in Chamberlain v. The Queen. Med J Aust (1984) 0.75
[Experimental pancreatic duct occlusion with polyurethane]. Helv Chir Acta (1989) 0.75